On the Probability of Random Genetic Mutations for Various Types of Tumor Growth

Bulletin of Mathematical Biology

Volumn 74, Issue 6, 2012, Pages 1379-1395

  Tomasetti, Cristian ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

Branching processes; Drug resistance; Genetic mutations; Ordinary differential equations; Stem cells; Tumor growth

Indexed keywords

ARTICLE; BIOLOGICAL MODEL; DRUG RESISTANCE; GENETICS; HUMAN; NEOPLASM; POINT MUTATION; STATISTICS;

DRUG RESISTANCE, NEOPLASM; HUMANS; MODELS, GENETIC; NEOPLASMS; POINT MUTATION; STOCHASTIC PROCESSES;

EID: 84861480120     PISSN: 00928240     EISSN: 15229602     Source Type: Journal    
DOI: 10.1007/s11538-012-9717-1     Document Type: Article

References (36)

1. Abkowitz, J. L., Persik, M. T., Shelton, G. H., Ott, R. L., Kiklevich, J. V., Catlin, S. N., & Guttorp, P. (1995). Behavior of hematopoietic stem cells in a large animal. Proc. Natl. Acad. Sci. USA, 92, 2031-2035.
2. Bellomo, N., Li, N. K., & Maini, P. K. (2008). On the foundations of cancer modeling: selected topics, speculations, and perspectives. Math. Models Methods Appl. Sci., 18, 593-646.
3. Booth, C., & Potten, C. S. (2000). Gut instincts: Thoughts on intestinal epithelial stem cells. J. Clin. Invest., 105, 1493-1499.
4. Coldman, A. J., & Goldie, J. H. (1985). Role of mathematical modeling in protocol formulation in cancer chemotherapy. Cancer Treat. Rep., 69(10), 1041-1048.
5. Coldman, A. J., & Goldie, J. H. (1986). A stochastic model for the origin and treatment of tumors containing drug-resistant cells. Bull. Math. Biol., 48(3-4), 279-292.
6. Gaffney, E. A. (2005). The mathematical modelling of adjuvant chemotherapy scheduling: incorporating the effects of protocol rest phases and pharmacokinetics. Bull. Math. Biol., 67(3), 563-611.
7. Giebel, B., Zhang, T., Beckmann, J., Spanholtz, J., Wernet, P., Ho, A. D., & Punzel, M. (2006). Primitive human hematopoietic cells give rise to differentially specified daughter cells upon their initial cell division. Blood, 107, 2146-2152.
8. Goldie, J. H., & Coldman, A. J. (1979). A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat. Rep., 63(11-12), 1727-1733.
9. Goldie, J. H., & Coldman, A. J. (1983a). A model for resistance of tumor cells to cancer chemotherapeutic agents. Math. Biosci., 65, 291-307.
10. Goldie, J. H., & Coldman, A. J. (1983b). Quantitative model for multiple levels of drug resistance in clinical tumors. Cancer Treat. Rep., 67(10), 923-931.
11. Goldie, J. H., & Coldman, A. J. (1998). Drug resistance in cancer: mechanisms and models. Cambridge: Cambridge University Press.
12. Goldie, J. H., Coldman, A. J., & Gudaskas, G. A. (1982). Rationale for the use of alternating non-cross resistant chemotherapy. Cancer Treat. Rep., 66(3), 439-449.
13. Hanahan, D., & Weinberg, R. A. (2000). The hallmarks of cancer. Cell, 100, 57-70.
14. Harnevo, L. E., & Agur, Z. (1991). The dynamics of gene amplification described as a multitype compartmental model and as a branching process. Math. Biosci., 103(1), 115-138.
15. Harnevo, L. E., & Agur, Z. (1993). Use of mathematical models for understanding the dynamics of gene amplification. Mutat. Res., 292(1), 17-24.
16. Iwasa, Y., Nowak, M. A., & Michor, F. (2006). Evolution of resistance during clonal expansion. Genetics, 172, 2557-2566.
17. Kimmel, M., & Axelrod, D. E. (1990). Mathematical models of gene amplification with applications to cellular drug resistance and tumorigenicity. Genetics, 125(3), 633-644.
18. Komarova, N. (2006). Stochastic modeling of drug resistance in cancer. J. Theor. Biol., 239(3), 351-366.
19. Komarova, N., & Wodarz, D. (2005). Drug resistance in cancer: principles of emergence and prevention. Proc. Natl. Acad. Sci. U. S. A., 102(27), 9714-9719.
20. Komarova, N., & Wodarz, D. (2009). Combination therapies against chronic myeloid leukemia: short-term versus long-term strategies. Cancer Res., 69(11), 4904-4910.
21. Komarova, N., Katouli, A. A., & Wodarz, D. (2009). Combination of two but not three current targeted drugs can improve therapy of chronic myeloid leukemia. PLoS ONE, 4(2), e4423.
22. Luria, S. E., & Delbruck, M. (1943). Mutation of bacteria from virus sensitivity to virus resistance. Genetics, 28, 491-511.
23. McKenzie, J. L., Gan, O. I., Doedens, M., Wang, J. C., & Dick, J. E. (2006). Individual stem cells with highly variable proliferation and self-renewal properties comprise the human hematopoietic stem cell compartment. Nat. Immunol., 7, 1225-1233.
24. Moolgavkar, S. H. (1986). Carcinogenesis modeling: from molecular biology to epidemiology. Annu. Rev. Public Health, 7, 151-169.
25. Morrison, S. J., & Kimble, J. (2006). Asymmetric and symmetric stem-cell divisions in development and cancer. Nature, 441, 1068-1074.
26. Murray, J. M. (1997). The optimal scheduling of two drugs with simple resistance for a problem in cancer chemotherapy. IMA J. Math. Appl. Med. Biol., 14, 283-303.
27. Nakasu, S., Nakasu, Y., Fukami, T., Jito, J., & Nozaki, K. (2010). Growth curve analysis of asymptomatic and symptomatic meningiomas. J. Neurooncology. doi: 10. 1007/s11060-010-0319-1.
28. Panetta, J. C., & Adam, J. (1995). A mathematical model of cycle-specific chemotherapy. Math. Comput. Model., 22, 67-82.
29. Retsky, J. (2011). Metronomic chemotherapy was originally designed and first used in 1994 for early stage cancer-why s it taking so long to proceed? Bioequiv. Availab. 3(4). doi: 10. 4172/jbb. 100000e6.
30. Teicher, B. A. (2006). Cancer drug resistance. Totowa: Humana Press.
31. Tomasetti, C., & Levy, D. (2010a). An elementary approach to modeling drug resistance in cancer. Math. Biosci. Eng., 7(4), 905-918.
32. Tomasetti, C., & Levy, D. (2010b). Drug resistance always depends on the turnover rate. In K. E. Herold & W. E. Bentley (Eds.), IFMBE proceedings (Vol. 32). New York: Springer.
33. Tomasetti, C., & Levy, D. (2010c). Role of symmetric and asymmetric division of stem cells in developing drug resistance. Proc. Natl. Acad. Sci. USA, 107(39), 16766-16771.
34. Wu, M., Kwon, H. Y., Rattis, F., Blum, J., Zhao, C., Ashkenazi, R., Jackson, T. L., Gaiano, N., Oliver, T., & Reya, T. (2007). Imaging hematopoietic precursor division in real time. Cell Stem Cell, 1, 541-554.
35. Yatabe, Y., Tavare, S., & Shibata, D. (2001). Investigating stem cells in human colon by using methylation patterns. Proc. Natl. Acad. Sci. USA, 98, 10839-10844.
36. Zheng, Q. (1999). Progress of a half century in the study of the Luria-Delbrück distribution. Math. Biosci., 162, 1-32.